In the same section, distinct MKI67-positive regions of the tumour show peak expression of APOBEC3B. Strong CDKN2A expression (the gene encoding p16INK4A, a biomarker for HPV-positive HNSCC) is evident throughout most of the tumour cells. This evidence concerns the gene CDKN2A and neoplasm.